Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEXO.L Regulatory News (EXO)

  • There is currently no data for EXO

Form 8 (OPD)

10 Apr 2017 10:11

RNS Number : 0515C
Element Materials Tech Group Ltd
10 April 2017
Β 

FORM 8 (OPD)

Β 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Element Materials Technology Group Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Exova Group plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

7 April 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

Β 

Β 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Β 

Class of relevant security:

Β 

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

Β 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

Β 

TOTAL:

Nil

0

Nil

0

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities

Β 

Class of relevant security in relation to which subscription right exists:

None.

Details, including nature of the rights concerned and relevant percentages:

None.

Β 

Β 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

None.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None.

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None.

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

Β 

Β 

Date of disclosure:

10 April 2017

Contact name:

Jo Wetz

Telephone number:

+44 (0)2035 401 823

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
FEEURRKRBWASARR
Date   Source Headline
19th Dec 20143:30 pmRNSDirector/PDMR Shareholding
16th Dec 20144:40 pmRNSSecond Price Monitoring Extn
16th Dec 20144:35 pmRNSPrice Monitoring Extension
12th Dec 20144:40 pmRNSSecond Price Monitoring Extn
12th Dec 20144:35 pmRNSPrice Monitoring Extension
10th Dec 201410:00 amRNSManagement Change
20th Nov 20143:40 pmRNSDirector/PDMR Shareholding
19th Nov 20144:30 pmRNSTR-1: Notification of Major Interest in Shares
19th Nov 20147:00 amRNSTrading Update
4th Nov 20144:40 pmRNSSecond Price Monitoring Extn
4th Nov 20144:35 pmRNSPrice Monitoring Extension
30th Oct 20144:35 pmRNSPrice Monitoring Extension
27th Oct 20144:40 pmRNSSecond Price Monitoring Extn
27th Oct 20144:35 pmRNSPrice Monitoring Extension
21st Oct 20143:11 pmRNSTR-1: Notification of Major Interest in Shares
17th Oct 20144:40 pmRNSSecond Price Monitoring Extn
17th Oct 20144:35 pmRNSPrice Monitoring Extension
13th Oct 20144:35 pmRNSPrice Monitoring Extension
3rd Oct 20149:40 amRNSHolding(s) in Company
1st Oct 20143:30 pmRNSTotal Voting Rights
30th Sep 20149:26 amRNSNotification of transaction of PDMRs
11th Sep 20149:10 amRNSHolding(s) in Company
4th Sep 20145:15 pmRNSIssue of Equity
4th Sep 201411:10 amRNSDirector/PDMR Shareholding
3rd Sep 20141:45 pmRNSDirector/PDMR Shareholding
29th Aug 20147:00 amRNS2014 Half Year Results
21st Jul 20148:00 amRNSAcquisition
30th Jun 20147:00 amRNSAnalyst Site Visit
3rd Jun 201410:08 amRNSDirector/PDMR Shareholding
3rd Jun 201410:03 amRNSAppointment of Joint Corporate Brokers
28th May 201411:18 amRNSNotification of new directorship
19th May 20147:00 amRNSInterim Management Statement
15th May 20141:52 pmRNSTR-1: Notification of major interest in shares
12th May 20144:14 pmRNSTR-1: Notification of major interest in shares
9th May 20145:00 pmRNSExova Group PLC - End of Stabilisation Notice
9th May 20144:54 pmRNSExercise of Over-allotment Option
28th Apr 20143:15 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20149:30 amRNSDirector/PDMR Shareholding
22nd Apr 20149:30 amRNSTR-1: Notification of major interest in shares
22nd Apr 20149:30 amRNSTR-1: Notification of major interest in shares
16th Apr 20148:24 amRNSDirector Declaration
16th Apr 20148:01 amRNSAdmission to Listing on LSE
11th Apr 201412:27 pmRNSPublication of Prospectus
11th Apr 20147:01 amRNSStabilisation Notice
11th Apr 20147:00 amRNSAnnouncement of Offer Price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.